||ATI-2341, pepducin targeting the C-X-C chemokine receptor type 4 (CXCR4), is an allos...
||Baohuoside I exhibits anti-inflammatory activity and anti-osteoporosis activities. B...
||Plerixafor octahydrochloride(AMD3100 8HCl) is a chemokine receptor antagonist for CXC...
||SRT3109 is a CXCR2 ligand for use in the treatment of chemokine mediated diseases and...
||UNBS5162 is a novel naphthalimide that decreases CXCL chemokine expression in experim...
||SB225002 is a potent, and selective CXCR2 antagonist with IC50 of 22 nM for inhibitin...
||Plerixafor is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxi...
||WZ811 is a novel small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM.